Use of human menopausal gonadotropin for the induction of ovulation

Abstract Experience with the use of human menopausal gonadotropins for the induction of ovulation is reported in 62 patients. Twenty-six pregnancies were achieved. Twenty-one pregnancies occurred during the first 3 months of treatment, suggesting that the chances for successful therapy decline significantly after this initial period. While the over-all beneficial effect to specific patients is undeniable, selection of this treatment requires a careful consideration of pretreatment diagnosis, risks involved, and also a natural history in terms of spontaneous remission of the functional anomalies to be treated.